首页|miR-17-5p通过调控PTEN/Akt通路介导乳腺癌细胞顺铂耐药

miR-17-5p通过调控PTEN/Akt通路介导乳腺癌细胞顺铂耐药

扫码查看
目的 探讨miR-17-5p通过调控PTEN/Akt通路介导乳腺癌细胞顺铂(DDP)耐药的作用。方法 采用DDP浓度梯度递增培养MCF-7/DDP耐药细胞株,通过RT-qPCR检测MCF-7及MCF-7/DDP耐药细胞中miR-17-5p含量。将MCF-7细胞分为miR-NC组和miR-17-5p组,分别转染miR-NC及miR-17-5p mimics质粒;将MCF-7/DDP 耐药细胞分为 anti-miR-NC 组和 anti-miR-17-5p 组,分别转染 anti-miR-NC 及 anti-miR-17-5p 质粒。通过 RT-qPCR检测转染效率,MTT法评估转染后各组细胞对DDP的敏感性,Transwell法用于获取miR-17-5p对乳腺癌细胞侵袭能力的直接作用,流式细胞术检测细胞凋亡率。双荧光素酶报告基因实验验证miR-17-5p和PTEN的靶向关系,Western blot法检测miR-17-5p调控下细胞凋亡和PTEN/Akt通路关键蛋白的变化。结果 相较MCF-7细胞,MCF-7/DDP耐药细胞中miR-17-5p表达量异常升高,PTEN表达量降低(P<0。01),PTEN作为靶基因受miR-17-5p调控。与miR-NC组相比,miR-17-5p组增殖抑制率显著降低,侵袭细胞数增加,凋亡率下降(均P<0。05),PTEN/Akt通路中抑癌蛋白 PTEN、p21、p27 表达降低,p-Akt308、p-Akt473、cyclin D1 表达升高(P<0。01)。与 anti-miR-NC 组相比,anti-miR-17-5p组增殖抑制率提高,侵袭细胞数减少,凋亡率上升(均P<0。05),抑癌蛋白PTEN、p21、p27表达升高,p-Akt308、p-Akt473、cyclin D1表达降低(P<0。01)。结论 敲低miR-17-5p可有效提高乳腺癌细胞的DDP敏感性,减弱其侵袭能力,诱导其凋亡,这可能与miR-17-5p对PTEN/Akt通路的调控作用有关。
MiR-17-5p mediating cisplatin resistance in breast cancer cells by regulating PTEN/Akt pathway
AIM To investigate the role of miR-17-5p in mediating cisplatin(DDP)resistance in breast cancer cells by regulating the PTEN/Akt pathway.METHODS MCF-7/DDP-resistant cell line was cultured with a gradient of increasing DDP concentrations.The content of miR-17-5p was detected in MCF-7 and MCF-7/DDP cells by RT-qPCR.MCF-7 cells were divided into miR-NC and miR-17-5p groups,and transfected with miR-NC and miR-17-5p mimics plasmids,respectively.MCF-7/DDP-resistant cells were divided into anti-miR-NC and anti-miR-17-5p groups,and transfected with anti-miR-NC and anti-miR-17-5p plasmids,respectively.Transfection efficiency was defined by RT-qPCR.The drug sensitivity of DDP in each group of transfected cells was evaluated by MTT.The direct effect of miR-17-5p on the invasive ability was obtained by Transwell assay.DDP-induced apoptosis of MCF-7 and MCF-7/DDP cells after transfection was analyzed by flow cytometry.The targeting relationship between miR-17-5p and PTEN was verified by double luciferase reporter gene assay.The changes of apoptosis and key proteins of PTEN/Akt pathway under the regulation of miR-17-5p were detected by Western blot.RESULTS Compared with MCF-7 cells,the miR-17-5p expression in MCF-7/DDP-resistant cells was abnormally increased,while the PTEN expression was reduced(P<0.01).PTEN was regulated by miR-17-5p as a target gene.Compared with the miR-NC group,the proliferation inhibition rate in the miR-17-5p mimics group was significantly declined,the number of invaded cells was enhanced,and the apoptosis rate was also decreased(P<0.05),and the expressions of tumor suppressor proteins PTEN,p21 and p27 in the PTEN/Akt pathway were decreased,and the expressions of p-Akt308,p-Akt473 and cyclin D1 were increased(P<0.01).Compared with the anti-miR-NC group,the proliferation inhibition rate was increased in the anti-miR-17-5p group,the number of invaded cells was decreased,and the apoptosis rate was also increased(P<0.05),and the expression of tumor suppressor proteins PTEN,p21 and p27 was increased,and the expression of p-Akt308,p-Akt473 and cyclin D1 was decreased(P<0.01).CONCLUSION Knockdown of miR-17-5p can effectively improve the DDP sensitivity of breast cancer cells,attenuate the invasive ability,and induce further apoptosis,which may be related to the regulatory effect of miR-17-5p on the PTEN/Akt pathway.

cisplatinbreast neoplasmsdrug susceptibilityapoptosisPTEN/Akt pathway

赵妍、吉柳、孙成鹏、赵心宇、武文慧

展开 >

大连市妇女儿童医疗中心(集团)春柳妇产院区药剂科,辽宁大连 116000

大连医科大学药学院,辽宁 大连 116000

大连医科大学检验医学院,辽宁 大连 116000

顺铂 乳腺肿瘤 药物敏感性 细胞凋亡 PTEN/Akt通路

2024

中国新药与临床杂志
中国药学会 上海市食品药品监督管理局科技情报研究所

中国新药与临床杂志

CSTPCD北大核心
影响因子:0.967
ISSN:1007-7669
年,卷(期):2024.43(11)